Rite Aid Corp. (NYSE:RAD)‘s stock had its “buy” rating reiterated by analysts at Deutsche Bank in a research report issued to clients and investors on Friday, AnalystRatings.Net reports.
A number of other analysts have also recently weighed in on RAD. Analysts at Imperial Capital initiated coverage on shares of Rite Aid Corp. in a research note to investors on Thursday, November 21st. They set an “outperform” rating and a $6.50 price target on the stock. Separately, analysts at Zacks upgraded shares of Rite Aid Corp. from a “neutral” rating to an “outperform” rating in a research note to investors on Thursday, October 10th. They now have a $5.30 price target on the stock. Finally, analysts at Raymond James raised their price target on shares of Rite Aid Corp. from $5.00 to $6.00 in a research note to investors on Tuesday, October 8th. They now have an “outperform” rating on the stock. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $4.67.
Rite Aid Corp. (NYSE:RAD) opened at 5.2789 on Friday. Rite Aid Corp. has a 52 week low of $1.26 and a 52 week high of $6.15. The stock’s 50-day moving average is $5.47 and its 200-day moving average is $4.17. The company has a market cap of $4.957 billion and a price-to-earnings ratio of 17.64.
Rite Aid Corp. (NYSE:RAD) last announced its earnings results on Thursday, December 19th. The company reported $0.04 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.04. The company had revenue of $6.36 billion for the quarter, compared to the consensus estimate of $6.30 billion. During the same quarter last year, the company posted $0.07 earnings per share. Rite Aid Corp.’s revenue was up 1.9% compared to the same quarter last year. Analysts expect that Rite Aid Corp. will post $0.23 EPS for the current fiscal year.
Rite Aid Corporationis a retail drugstore chain in the United States. As of March 3, 2012, the Company operated drugstores in 31 states across the country and in the District of Columbia.